Novartis brings 4 presentations to BPI 2026 in Boston, and exhibits at Booth 921. Its program covers faster cell line engineering and scaling ex vivo cell therapy manufacturing. One discussion shares lessons on selecting a contract manufacturer, told from the manufacturer's side.
| Organization | BPI 2026 Attendance |
|---|---|
Novartis Basel, Switzerland | 1 Associate Director · 1 Associate Director, Science and Technology, Cell & Gene Therapy · 1 Senior Scientist, Analytical Development, Cell & Gene Therapy · 1 Associate Director Business Development |
Global pharmaceutical company developing and manufacturing biologics and cell and gene therapies; also offers contract manufacturing capacity. | Booth Exhibiting at Booth 921 Wed, Sep 233:30pm–7:00pmThu, Sep 248:15am–5:00pmFri, Sep 259:00am–1:50pm Talk Wed Sep 23 2:30pm–3:00pm Panel Thu Sep 24 9:30am–10:30am Chair Fri Sep 25 8:50am–9:00am Talk Fri Sep 25 10:00am–10:30am |
Instantly find 20 buyers from Novartis
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction